Following a three-day bench trial in the matter on June 5-7, 2017 and after having considered the entire record in the case and the applicable law, the Court, through Trial Opinion, entered by The Honorable Richard G. Andrews in Orexigen Therapeutics, Inc. v. Actavis Laboratories FL, Inc., Civil Action No. 15-451-RGA (D.Del. October 13,
no invalidity
Judge Sleet Finds Patent-In-Suit Is Not Invalid for Lack of Patentable Subject Matter
By Gregory B. Williams on
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Vanda Pharmaceuticals Inc., et al. v. Roxane Laboratories, Inc., Civil Action No. 13-1973-GMS (D.Del., August 25, 2016) (consolidated), the Court, following a five-day bench trial and having considered the entire record in the case (including but not limited to the parties’ post-trial proposed…
Judge Sleet Concludes that Defendants Did Not Prove Invalidity of Asserted Claim in ANDA Action
By Gregory B. Williams on
Following a four day bench trial in a consolidated ANDA action before The Honorable Gregory M. Sleet in Genzyme Corp., et al. v. Dr. Reddy’s Laboratories, Ltd., et al., Civil Action Nos. 13-1506 and 13-1508-GMS (D.Del., May 11, 2016), the Court issued its findings of fact and conclusions of law pursuant to Federal Rule…
Chief Judge Stark Grants Plaintiffs’ Motion for Summary Judgment in Part as to No Invalidity of Patent-in-Suit
By Gregory B. Williams on
Posted in Intellectual Property, Patent Infringement
By Memorandum Opinion entered by The Honorable Leonard P. Stark in Fairchild Semiconductor Corp. v. Power Integrations, Inc., Civil Action No. 12-540-LPS (D.Del., May 4, 2015), the Court granted plaintiffs’ motion for summary judgment in part as to no invalidity of U.S. Patent Number 7,525,259 (“the ‘259 patent”) due to lack of enablement, lack…
After Bench Trial, Judge Sleet Concludes that None of the Asserted Claims of the Patents-in-Suit Are Invalid Due to Obviousness
By Gregory B. Williams on
Posted in Patent Infringement
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Pfizer Inc., et al. v. Mylan Pharmaceuticals Inc., C.A. No. 10-528-GMS (D.Del., October 22, 2014), the Court, following a four day bench trial and after having considered the entire record in the case and the applicable law, concluded that none of the asserted…
After Bench Trial, Judge Sleet Concludes that Hospira’s Proposed Product Does Not Infringe the Patent-in-Suit Asserted by Abbvie
By Gregory B. Williams on
Posted in Intellectual Property, Patent Infringement
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Abbvie Inc. v. Hospira, Inc., C.A. No. 11-648- GMS (D.Del., October 24, 2014), the Court, following a two day bench trial and after having considered the entire record in the case and the applicable law, concluded that (1) the asserted claims of the…
Judge Robinson Grants Palm’s and Intermec’s Motions For Summary Judgment on Invalidity and Infringement in Part
By Gregory B. Williams on
Posted in District of Delaware, Patent Infringement
By Memorandum Opinion entered by The Honorable Sue L. Robinson in Intermec Technologies Corp. v. Palm Inc., Civil Action No. 07-272-SLR (D.Del., September 15, 2011), the Court granted Defendant Palm Inc.’s (“Palm”) motion for summary judgment relating to its infringement counterclaims in part by finding no invalidity as to its U.S. Patent Nos. 6,665,803 …